18FDG-PET applications for cartilage neoplasms

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Cartilage neoplasms present diagnostic challenges, especially with ambiguous histologic, imaging, or clinical features.
• Accurate differentiation between benign and malignant cartilage lesions is crucial for appropriate patient management.

Purpose of the Study:

• To evaluate the utility of whole-body [18F]fluoro-2-deoxy-D-glucose positron emission tomography (18FDG-PET) in characterizing aggressive cartilage neoplasms.
• To assess the effectiveness of 18FDG-PET in differentiating benign from malignant cartilage lesions.

Main Methods:

• Twenty-nine cartilage lesions in 29 patients (20 females, 9 males; age 11-85 years) were studied using whole-body 18FDG-PET scans between 2000 and 2003.
• Maximum Standardized Uptake Values (SUVs) were analyzed, with a cutoff SUV of 2.0 used to classify lesions as benign or malignant.
• Results were correlated with postoperative histopathologic findings.

Main Results:

• Whole-body 18FDG-PET demonstrated high diagnostic performance in differentiating benign and malignant cartilage lesions.
• The overall sensitivity was 90.9% (10/11), specificity was 100% (18/18), and accuracy was 96.6% in 26 operated cases.

Conclusions:

• Whole-body 18FDG-PET is a valuable tool for identifying primary, recurrent, and metastatic cartilage malignancies.
• This functional imaging modality complements traditional histology and morphologic imaging, providing data that can guide clinical decision-making.